| Literature DB >> 16513381 |
Jonas Klingström1, Jonas Hardestam, Ake Lundkvist.
Abstract
Hantaviruses are the causative agents of HFRS and HCPS (hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome), two severe, and often fatal human diseases. Mortality from HFRS varies between hantaviruses; Hantaan and Dobrava show the highest, Seoul intermediate, and Puumala low mortality. Saaremaa, genetically closely related to Dobrava, is also known to induce HFRS, with low or no mortality. In this study, mice were inoculated with Dobrava and Saaremaa viruses to test for infectibility, lethality, viremia, nitric oxide production and antibody responses. Out of suckling mice intracerebrally inoculated with 50, 500 and 5,000 focus-forming units of Dobrava virus, respectively, 1/8, 2/8 and 7/8 died within 18-26 days. In all but one of the lethally infected mice high levels of replicating virus were detected, and most were positive for neutralizing antibodies and showed elevated levels of nitric oxide production. All suckling mice intracerebrally inoculated with 50, 500, or 5,000 focus-forming units of Saaremaa virus survived and all seroconverted. Clearly lower viral titers were observed for the Saaremaa virus-inoculated mice, also when sacrificed at day 18 after infection, compared to those in mice that died following Dobrava virus infection. Dobrava, Saaremaa, Puumala and Hantaan virus infections of adult mice were asymptomatic, and the anti-nucleocapsid protein IgG2a/IgG1-titer ratio was higher in mice inoculated with Dobrava virus than in those inoculated with Saaremaa virus. Elevated nitric oxide production was not detected in asymptomatically infected mice, and iNOS-/- mice, like normal mice, cleared viremia. In conclusion, we show that Dobrava virus and Saaremaa virus induce distinct differences in terms of survival, viremia, nitric oxide production and antibody responses in mice.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16513381 PMCID: PMC7110477 DOI: 10.1016/j.micinf.2005.09.010
Source DB: PubMed Journal: Microbes Infect ISSN: 1286-4579 Impact factor: 2.700
DOBV in suckling mice
| ID | Inoculated with | Outcome | Detection of virus/RNA in brain | Antibody titer | |
|---|---|---|---|---|---|
| IgG | Neut. | ||||
| 1:1 | Inactivated | S | − | − | − |
| 1:2 | Inactivated | S | − | − | − |
| 1:3 | Inactivated | S | − | − | − |
| 1:4 | Inactivated | S | − | − | − |
| 1:5 | Inactivated | S | − | − | − |
| 1:6 | Inactivated | S | − | − | − |
| 1:7 | Inactivated | S | − | − | − |
| 1:8 | Inactivated | S | − | − | − |
| 3:1 | 5000 FFU | † (d. 18) | + (1 × 106) | − | 80 |
| 3:2 | 5000 FFU | † (d. 18) | + (3 × 106) | − | 20 |
| 3:3 | 5000 FFU | † (d. 18) | + (3 × 106) | − | 20 |
| 3:4 | 5000 FFU | † (d. 18) | + (1.5 × 106) | − | − |
| 3:5 | 5000 FFU | S | − (+ in PCR) | 810 | 80 |
| 3:6 | 5000 FFU | † (d. 18) | + (5 × 106) | − | 40 |
| 3:7 | 5000 FFU | † (d. 18) | + (2 × 106) | − | − |
| 3:8 | 5000 FFU | † (d. 20) | + (1 × 106) | − | 20 |
| 4:1 | 500 FFU | S | − | − | − |
| 4:2 | 500 FFU | S | − | − | − |
| 4:3 | 500 FFU | S | − (+ in PCR) | 270 | 40 |
| 4:4 | 500 FFU | S | − | − | − |
| 4:5 | 500 FFU | S | − (+ in PCR) | 810 | 80 |
| 4:6 | 500 FFU | S | − | − | − |
| 4:7 | 500 FFU | † (d. 20) | + (2.5 × 106) | − | 40 |
| 4:8 | 500 FFU | † (d. 20) | + (3 × 106) | − | 40 |
| 5:1 | 50 FFU | S | − | − | − |
| 5:2 | 50 FFU | S | − | − | − |
| 5:3 | 50 FFU | S | − (+ in PCR) | 810 | 80 |
| 5:4 | 50 FFU | S | − | − | − |
| 5:5 | 50 FFU | S | − (+ in PCR) | 810 | 40 |
| 5:6 | 50 FFU | S | − | 270 | − |
| 5:7 | 50 FFU | S | − (+ in PCR) | 810 | 160 |
| 5:8 | 50 FFU | † (d. 26) | − (+ in PCR) | 90 | 40 |
S, survived.
Virus from brains was titrated on Vero E6 cells, FFU/brain in brackets, + in PCR, negative for replicating virus, but positive for RT-PCR on DOBV/SAAV S, −, negative for replicating virus and RT-PCR.
Reciprocal anti-DOBV N protein-IgG titer. −, Negative at 10× dilution of sample.
Neutralizing antibody titer. −, Negative at 20× dilution of sample.
Heat-inactivated DOBV, corresponding to 5000 FFU, was administered.
† d. 18, 20 or 26, died at day 18, 20 or 26 after infection.
SAAV in suckling mice
| ID | Inoculated with | Outcome | Isolation of replicating virus | Antibody titer | |
|---|---|---|---|---|---|
| IgG | Neut. | ||||
| 2:1 | Inactivated | S | ND | − | − |
| 2:2 | Inactivated | S | ND | − | − |
| 2:3 | Inactivated | S | ND | − | − |
| 2:4 | Inactivated | S | ND | − | − |
| 2:5 | Inactivated | S | ND | − | − |
| 2:6 | Inactivated | S | ND | − | − |
| 2:7 | Inactivated | S | ND | − | − |
| 2:8 | Inactivated | S | ND | − | − |
| 6:1 | 5000 FFU | S | + (1 × 103) | 2430 | 80 |
| 6:2 | 5000 FFU | S | + (1 × 103) | 270 | 40 |
| 6:3 | 5000 FFU | S | − | 810 | − |
| 6:4 | 5000 FFU | S | − | 810 | 20 |
| 6:5 | 5000 FFU | S | − (+ in PCR) | 270 | 40 |
| 6:6 | 5000 FFU | S | − (+ in PCR) | 90 | 40 |
| 6:7 | 5000 FFU | S | + (0.5 × 103) | 90 | 40 |
| 6:8 | 5000 FFU | S | − (+ in PCR) | 270 | − |
| 7:1 | 500 FFU | S | − (+ in PCR) | 810 | 40 |
| 7:2 | 500 FFU | S | − (+ in PCR) | 810 | 40 |
| 7:3 | 500 FFU | S | − (+ in PCR) | 810 | 40 |
| 7:4 | 500 FFU | S | − (+ in PCR) | 270 | − |
| 7:5 | 500 FFU | S | − (+ in PCR) | 810 | 80 |
| 7:6 | 500 FFU | S | + (5 × 103) | 810 | 40 |
| 7:7 | 500 FFU | S | + (0.5 × 103) | 270 | 20 |
| 7:8 | 500 FFU | S | − | 810 | 20 |
| 8:1 | 50 FFU | S | + (1 × 103) | 810 | 160 |
| 8:2 | 50 FFU | S | − | 270 | 20 |
| 8:3 | 50 FFU | S | − (+ in PCR) | 810 | − |
| 8:4 | 50 FFU | S | − | 270 | 40 |
| 8:5 | 50 FFU | S | − | 270 | 80 |
| 8:6 | 50 FFU | S | − | 90 | − |
| 8:7 | 50 FFU | S | − | 270 | − |
S, survived, ND, not determined.
Virus from brains was titrated on Vero E6 cells, FFU/brain in brackets, + in PCR, negative for replicating virus, but positive for RT-PCR on DOBV/SAAV S, −, negative for replicating virus and RT-PCR.
Reciprocal anti-DOBV N protein-IgG titer. −, Negative at 10× dilution of sample.
Neutralizing antibody titer. −, Negative at 20× dilution of sample.
Heat-inactivated SAAV, corresponding to 5000 FFU, was administered.
Virus titers in suckling mice infected with 5000 FFU SAAV and sacrificed at day 18 after infection
| ID | Isolation of replicating virus |
|---|---|
| 9:1 | + (5 × 104) |
| 9:2 | + (5 × 105) |
| 9:3 | + (2.5 × 104) |
| 9:4 | + (1.5 × 105) |
| 9:5 | + (1.5 × 103) |
| 9:6 | + (1.5 × 105) |
| 9:7 | + (2.5 × 104) |
| 9:8 | + (5 × 104) |
Virus from brains was titrated on Vero E6 cells, FFU/brain in brackets.
Levels of nitrite in brains from suckling mice after DOBV and SAAV infection
| Inoculated with | Outcome | Nitrite, μM (mean ± sd) | |
|---|---|---|---|
| DOBV | 10 | † (d. 18–26) | 31.52 ± 17.01 |
| 7 | S, infected | 18.26 ± 9.05 | |
| 7 | S, uninfected | 18.02 ± 3.18 | |
| Inactivated DOBV | 8 | S | 17.52 ± 6.80 |
| 8 | S | 14.15 ± 0.63 | |
| SAAV | 23 | S, infected | 16.37 ± 2.34 |
| 8 | S, infected | 16.00 ± 1.10 | |
| Inactivated SAAV | 8 | S | 15.08 ± 2.62 |
| Control, no virus | 6 | S | 15.15 ± 0.86 |
Brain nitrite levels were determined after conversion of nitrate to nitrite.
S, survived.
† d. 18–26, died at days 18–26 after infection.
Sacrificed at day 34 after infection.
Sacrificed at day 18 after infection.
Fig. 1Levels of nitrite in brains from DOBV lethally infected suckling mice. Data shown are the level of nitrite detected in brain at the time of death.
Fig. 2PUUV, SAAV, TOPV and TULV are not lethal for suckling mice. Survival was measured in suckling mice after intracerebral inoculation with 8000 FFU of DOBV (n = 16), 100 FFU of HTNV (n = 8), 18,000 FFU of SEOV (n = 8), 200 bank vole ID50 of PUUV Kazan-wt (n = 8), 5000 FFU of PUUV Sotkamo (n = 5), 20,000 FFU of PUUV esc-5A2 (n = 8), 10,000 FFU of SAAV (n = 8), 900 FFU of TOPV (n = 8) or 1800 FFU of TULV (n = 8).
Fig. 3Total IgG and IgG subclass responses against N in sera from adult NMRI mice 60 days after DOBV, HTNV, PUUV Kazan-wt and PUUV Kazan-E6 p6 inoculation and 49 days after SAAV inoculation. (A) IgG anti-N responses. (B) IgG subclass anti-N responses in pooled sera from four mice inoculated intravenously with PUUV Kazan-wt (1000 bank vole ID50), four mice inoculated intravenously with PUUV Kazan-E6 (25,000 FFU), three mice inoculated intravenously with HTNV (90,000 FFU), four mice inoculated intravenously and subcutaneously with DOBV (80,000 FFU), and eight mice inoculated intravenously and subcutaneously with SAAV (100,000 FFU).
Fig. 4IgG2a/IgG1 ratio in intraperitoneally infected BALB/c mice 43 days after infection. Data shown represent mean ± SD of six mice/group.
Fig. 5HTNV infection of C57/BL6 mice does not induce NO production. The total level of nitrate/nitrite in sera of HTNV-infected mice (n = 6) was measured by reduction of nitrate to nitrite and then the amount of nitrite was measured. The data represent mean ± SD.
Fig. 6Antibody responses in C57/BL6 and iNOS−/− mice after HTNV infection. (A) IgG subclass specific response against N protein. (B) Neutralizing titers against HTNV. The data represent mean + SD.